In patients with pulmonary hypertension (PH), ascertaining raised vascular resistance as a cause is a clinical objective, for which various Doppler-based measurements have been proposed, but with modest accuracy. We hypothesize that pulmonary acceleration time (PAcT) and the ratio of PAcT/peak pulmonary artery systolic pressure (PASP) reflect better the extent of the vascular resistance, compared with other available methods, and can differentiate accurately between pre-and post-capillary PH.
Introduction
Identifying patients with pre-capillary pulmonary arterial hypertension is important in refining the diagnosis and optimizing treatment. 1 Although non-invasive estimation of pulmonary artery systolic pressure (PASP) by Doppler echocardiography is well established, 2 it does not differentiate pre-capillary from postcapillary pulmonary hypertension (PH), caused by left heart disease, 3 hence the need for an accurate measurement of pulmonary vascular resistance (PVR). 4 PVR reflects both the pulmonary circulation disease and pulmonary capillary wedge pressure (PCWP) but is conventionally estimated from right heart catheterization (RHC), with its known invasive limitation. Recent studies have shown the potential use of different echocardiographic modalities in assessing PVR. 5 -7 We have recently shown that Doppler echocardiographic measurements of PVR strongly correlate with RHC-based measures and are able to identify individual patients with disease. 8 A limitation with such approach is its modest accuracy in estimating PCWP. Therefore, we hypothesized in this study that the time the right ventricular takes to achieve peak ejection, e.g. acceleration time (PAcT), should determine the peripheral PVR.
Methods
We investigated 56 patients (mean age 61 + 13 years, 23 males) with different diagnoses ( 
Right heart catheterization
A retrograde catheterization of the pulmonary circulation was performed using Swan -Ganzw standard method with thermodilution catheters (Edwards Life sciences) through a medial cubital vein or the femoral vein. 9 Mean right atrial pressure, systolic and end-diastolic right ventricular pressures, mean (PAMP), systolic (PASP), and diastolic pulmonary artery pressures, and PCWP were measured. Oxygen saturation was estimated in caval veins, right atrium, and pulmonary and femoral arteries for screening for intra-cardiac shunts. Cardiac output (CO) was determined by thermodilution or by Fick's method when appropriate. PVR was calculated using the equation PVR ¼ PAMP -PCWP (trans-pulmonary gradient) divided by CO.
Echocardiographic examination
The echocardiographic examination was performed simultaneously with the RHC for all subjects. A Vivid 7 system (GE Medical Systems, Horten, Norway) equipped with an adult 1. The study protocol was approved by the Regional Ethics Committee of Umeå (DNR 07 -092M), and all subjects gave an informed consent.
Measurements
Analysis of the acquired images was performed using the commercially available off-line software system (Echo PAC version 6.0.1, Waukesha, GE, USA). LA volume was measured by manually drawing maximum LA volume during ventricular systole from the four-chamber view. LV dimensions were measured from M-mode recordings of the basal region, using conventional methods. 11 LV ejection fraction was measured using the single-plane Simpson technique and CO was calculated using the methods proposed by the European Society of Cardiology and American Society of Echocardiography. 12,13 LV lateral wall myocardial velocities were studied using pulsed-wave tissue Doppler imaging (TDI) technique, with the sample volume placed 1 cm proximal to the mitral annulus level. From the TDI recordings, we measured the peak annulus systolic velocity (s ′ ) and the early diastolic velocity (e ′ ). The LV filling pattern was obtained from the transmitral Doppler velocities, with the pulsed-wave Doppler sample volume placed at the tips of the mitral valve leaflets from the apical fourchamber view. From LV filling recordings, we measured the peak early (E) diastolic velocity and E-wave deceleration time, and the E/A ratio was calculated. LV isovolumic relaxation time (IVRT) was measured as the time interval between LV end-ejection (from the pulsedwave Doppler recording of the outflow tract velocity) and the onset of transmitral E-wave velocity. The E/e ′ ratio was also calculated and taken as an index of raised LV filling pressures. Pulmonary artery flow was measured by placing the pulsed-wave Doppler sample volume at the centre of the trans-pulmonary valve jet, obtained from the short-axis view. From this envelope, we measured the pulmonary artery velocity time integral (VTIrvot) and the acceleration time (PAcT) as the interval between the onset of ejection and the peak flow velocity ( Figure 1 ). As PAcT has been shown to be heart rate-dependent, 14 we corrected for heart rate, using the formula PAcT/ p RR (s). Retrograde systolic transtricuspid regurgitant flow, reflecting PASP, was obtained from either the parasternal right ventricular inflow view or the apical four-chamber view for measuring peak tricuspid pressure drop, using continuous-wave Doppler and the modified Bernoulli equation P ¼ 4V 2 . 15 Right atrial pressure was estimated at 7 mmHg in all patient groups based on previous findings. 8 Right ventricular free wall myocardial deformation was assessed using speckle tracking echocardiography technique, from the apical four-chamber view. Effort was made to include the RV free wall by an optimal RV acquisition. Analysis of the acquired images was performed using the commercially available semi-automated twodimensional (2D) strain software (Echo PAC version 5.0.1, Waukesha, GE, USA). One cardiac cycle was selected, from which end-diastolic frame was determined in the apical four-chamber view (mean frame 60 -70 fps). RV wall was tracked on a frame-to-frame basis and the endocardial border was traced to delineate the region of interest. This was composed of three segments of the RV, base, mid-cavity, and apical. Only clearly displayed segments were accepted by the software, which provided their detailed analysis throughout the cardiac cycle. The mean strain of the three segments was calculated. 
Results

Cardiac function in the patient groups
Basic characteristic data are shown in Table 1 . A one-way ANOVA analysis confirmed that the mean age differed between the four groups; however, there was no age difference between those with pre-capillary (Group 2) and post-capillary PH (Group 4). Groups 2-4 had all increased PASP and significantly higher values compared with Group 1. Group 2 had higher PVR (P , 0.001) but lower PCWP (P , 0.001) than Group 4 (inclusion criterion). CO did not differ between Group 2 and Group 4. Compared with Group 2, Group 4 had increased LA volume (P , 0.05), raised E/A ratio (P , 0.001), and prolonged IVRT (P , 0.01), but E-wave deceleration time and E/e ′ were not different. LV myocardial velocities were not different between groups ( Table 2) .
PAcT in predicting PVR
PAcT correlated modestly with PASP (r ¼ 20.60, P , 0.001) and PVR (r ¼ 20.57, P , 0.001) and slightly improved in a quadratic regression line (r ¼ 20.61, P , 0.001) (Figure 2) . From this quadratic regression line analysis in individual subjects, a PAcT ≤90 ms showed a sensitivity of 84%, a specificity of 85%, and positive and negative predictive values of 88% and 81%, respectively, in identifying patients with PVR ≥3 WU. PAcT in the four groups is shown in Figure 3 .
PAcT/PASP in predicting PVR
PAcT/PASP correlated more strongly with PVR (r ¼ 20.67, P , 0.001) and did also improve in a quadratic regression pattern (r ¼ 20.74, P , 0.001). A value of PAcT/PASP of ,2 was 83% sensitive and 79% specific in identifying patients with PVR ≥3 WU, with positive and negative predictive value of 83% and 79%, respectively ( Figure 4) . PAcT/PASP in the four groups is shown in Figure 5 . (Figure 6 ). PAcT of ,96 ms had the highest accuracy (83%) of detecting elevated PVR (Figure 7A and B; Table 4 ).
Discussion Findings
In this study, we have found a satisfactory relationship between pulmonary acceleration time (PAcT) and invasive measurements of PVR. PAcT correlated modestly with peak PASP but in a stronger way with PVR, with a value ,90 ms identifying most patients with PVR ≥3 WU. This relationship was further strengthened when we used the ratio of PAcT to peak sPAP, which again correlated with the vascular resistance, with a value ,2 predicting patients with a PVR of ≥3 WU with a highly satisfactory accuracy. Finally, in patients with elevated PASP, PAcT is an accurate measure in discriminating between patients with PH due to elevated PCWP or raised PVR.
Data interpretation
PH is common in clinical practice and is known for its multiple aetiologies. 16 Advances in medical management of PH lagged behind other cardiovascular syndromes, primarily due to the lack of Table 3 Haemodynamic data from RHC of the study cohort accurate early diagnosis of the condition, using non-invasive investigations, with invasive ones recommended in late stages of the disease. Even confident diagnosis of PH using 2D echocardiography was traditionally based on the identification of significant right heart structural changes rather than direct pressure measurements. 17 Spectral Doppler did revolutionize management of PH having allowed early diagnosis of the condition, using retrograde pressure drop across the tricuspid valve as an indirect measure of peak PASP. 18 The management dilemma however remains complicated by the difficulty in determining the exact pathophysiology of the condition, particularly in patients lacking overt evidence for left heart pathology, e.g. hypertensive LV disease. In such patients, establishing the extent of PVR is important for planning optimum management. 4 A number of equations have been proposed 5, 19, 20 and proved acceptable in their accuracy in reflecting raised PVR.
Our results add to those in showing that a simple measure of PAcT could provide an important tool in assessing PVR. In keeping with previously documented findings, 7, 20 we found that the shorter the acceleration time the higher the PVR, with a cut value ,90 ms being accurate enough to identify patients with .3 WU. Similar pulmonary acceleration values have previously been used to identify patients with PH, but hereby, for the first time, we demonstrated its applicability in differentiating patients with PH due to raised PVR from those caused by elevated left-side filling pressures (Groups 2 and 3) . The accuracy of the short PAcT further improved significantly when it was tested in relation to peak PASP, particularly with a ratio of ,2. These findings did not come with a surprise since the PAcT, in fact, represents pulmonary flow acceleration, which increases as the vascular resistance is augmented, based on the Newton law of motion. Furthermore, we found the relation between both PAcT and PAcT/PASP and PVR is not linear but rather quadratic, a finding compatible with that of Dabestani et al. 7 Finally, it seems that the main reason behind the superior accuracy of our proposed markers of raised PVR is them being direct reflectors of blood flow-pressure relationship rather than other indirect markers, i.e. RV function, as is the case with other equations. This advantage eliminates possible additional factors, e.g. myocardial function.
Clinical implications
In patients with PH, pulmonary artery acceleration time is an important measure reflecting the severity of PVR. The 20-year use of its absolute value of 90 or 100 ms in identifying patients with PVR .3 WU remains valid, and become even more accurate when applied relative to peak PASP, resulting in accurate cut-off value ,2 in identifying raised PVR patients. 
Limitations
The accuracy in obtaining pulmonary valve forward-flow velocities could be challenging for two reasons: (i) its anatomical displacement in patients with dilated pulmonary artery in PH and (ii) high pulsed-wave Doppler gain which might underestimate exact time measurements. Likewise, obtaining a clear signal of tricuspid regurgitation continuous-wave Doppler might not be optimum depending on technical imaging and personal expertise.
Conclusion
PAcT remains a valid simple method for identifying patients with raised vascular resistance. Its accuracy is further improved when used in relation to peak estimated sPAP measured from tricuspid regurgitation recordings. This simple method should have a clinical role in the daily management of PH, in particular for patients' follow-up as RHC is still the prerequisite for diagnosis of pre-vs. post-capillary PH. 
